Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 17Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 9Neoplasm Metastasis 6Prostatic Neoplasms 5Melanoma 5Lung Neoplasms 5Solid Tumor 3Pain, Postoperative 3Lymphoma, Non-Hodgkin 3Lymphoma 3Leukemia, Myeloid, Acute 3Gastrointestinal Stromal Tumors 3Colorectal Neoplasms 3Anxiety Disorders 3Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Pain 2Glioma 2Colonic Neoplasms 2Choledocholithiasis 2Choledochal Cyst 2Carcinoma 2Advanced Solid Tumor 2Advanced Malignancies 2cMET-dysregulated Advanced Solid Tumors 1Urothelial Cancer 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1

Interventions

Propofol 4Saline Solution 3Dexmedetomidine 3remimazolam 2Sugammadex 1Sufentanil 1Spectroscopy, Near-Infrared 1Sodium Chloride 1Ropivacaine 1Pyridostigmine Bromide 1Neuroleptanalgesia 1Nalbuphine 1Minocycline 1Midazolam 1Methylene Blue 1Ketamine 1Injections 1Ibuprofen 1Duloxetine Hydrochloride 1Blood Specimen Collection 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Emergence Delirium × Midazolam × Clear all
NCT05466279 2024-01-25

The Role of Remazolam in Reducing the Incidence of Postoperative Delirium in Elderly Patients

Zhejiang Cancer Hospital

Phase NA Completed
131 enrolled

Emergence Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡